You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 146 No. 11, November 1986 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL INVESTIGATIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (36)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Intensive Hospital Monitoring Study of Intravenous Cimetidine

Jane B. Porter, MS; Keith Beard, MB, ChB, MRCP; Alexander M. Walker, MD, DrPH; David H. Lawson, MD, FRCP; Hershel Jick, MD; Gavin S. M. Kellaway, MD

Arch Intern Med. 1986;146(11):2237-2239.


Abstract



• We studied the frequency of adverse reactions occurring in 1189 patients who received cimetidine intravenously, based on data collected as part of a hospital-based monitoring study of recently marketed drugs. There were 40 patients (3.4%) with adverse reactions, 23 of whom were considered to be "definitely" or "probably" related to cimetidine use and 17 patients in whom a causal association was possible. The most frequently reported reactions were neuropsychiatric disorders in 19 patients (1.6%) and leukopenia in eight patients (0.7%).

(Arch Intern Med 1986;146:2237-2239)



Author Affiliations



From the Boston Collaborative Drug Surveillance Program, Boston University Medical Center, Waltham, Mass (Ms Porter, Drs Beard, Walker, and Jick), the Department of Epidemiology, Harvard School of Public Health, Boston (Dr Walker), the Royal Infirmary, Glasgow, Scotland (Dr Lawson), and Auckland (New Zealand) Hospital (Dr Kellaway).


Footnotes



Accepted for publication Feb 25, 1986.

Reprint requests to Boston Collaborative Drug Surveillance Program, 400-1 Totten Pond Rd, Waltham, MA 02154 (Dr Jick).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cimetidine as adjunctive treatment for acetaminophen overdose
Burkhart et al.
Hum Exp Toxicol 1995;14:299-304.
ABSTRACT  

Report on Other Drug Use Among Persons Previously Reported to Have Received Intravenous Cimetidine
Jick
Arch Intern Med 1992;152:2145-2145.
ABSTRACT  

Central Nervous System Reactions to Histamine-2 Receptor Blockers
Cantu and Korek
ANN INTERN MED 1991;114:1027-1034.
ABSTRACT  

Histamine2-Receptor Antagonists and Cardiovascular Drugs-Reply
Lipsy et al.
Arch Intern Med 1991;151:815-815.
ABSTRACT  

Unrecognized Drug Interactions With Famotidine and Nizatidine
Karlstadt and Palmer
Arch Intern Med 1991;151:810-814.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.